IIQ formerly BD1BUZZ-Australia's Inoviq rises on Chinese patent for lung cancer test
Friday, 24th December 2021, 12:13:09 pm
- Shares of medical diagnostics co Inoviq Ltd (IIQ) rise as much as 4.2% to A$1.115, their biggest intraday pct. gain since Dec. 17
- Co says it has been granted a Chinese patent covering lung cancer diagnosis
- Patent protects co's BARD1 autoantibody test for diagnosis of lung cancer in China
- Stock up 57.4% YTD, as of last close
- Forums
- ASX - Day Trading
- Morning/Afternoon trading Xmas Eve 2021
IIQ formerly BD1BUZZ-Australia's Inoviq rises on Chinese patent...
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online